Background: Effective treatment modalities for systemic sclerosis, a life-threatening and
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …

Background Extracorporeal photochemotherapy (photopheresis), an immune‐modulating
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …

BACKGROUND: Systemic sclerosis is a multisystemic connective tissue disease with
marked involvement of the skin and joints for which few effective evidence based therapies …

Background. Extracorporeal photochemotherapy, an immune‐modulating form of therapy,
has been shown to be effective in the treatment of autoimmune diseases. We evaluated the …

Background: Extracorporeal photochemotherapy (EXP) is an immunomodulating therapy
that has been used in a limited number of patients with systemic sclerosis (SSC) with …

• Background and Design.—In a pilot study of extracorporeal photochemotherapy, two
patients with systemic sclerosis who received this therapy experienced significant clinical …

Background: Extracorporeal photochemotherapy (EP) is a new immune-modulating therapy
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …

Background: Scleroderma is a heterogeneous group of diseases that can be localized or
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …

Background: The management of systemic sclerosis remains unsatisfactory. Thus far, the
action of extracorporeal photopheresis (ECP) in severe systemic scleroderma has been …

In this report, we describe the use of extracorporeal photochemotherapy in n the treatment of
two patients with rapidly advancing progressive systemic sclerosis. Both patients …